Despite, Rout

Despite a 5% Rout, Ams Osram’s Restructuring Story — from €1B Bond to AI Emitters — Stays Intact

05.06.2026 - 05:21:00 | boerse-global.de

Broadcom's flat AI revenue guidance sparks profit-taking in European chip stocks, but Ams Osram's 158% YTD rally reflects operational turnaround and pivot to AI and AR.

European Chip Stocks Slide on Broadcom AI Caution; Ams Osram Up 158% YTD
Despite - Despite a 5% Rout, Ams Osram’s Restructuring Story — from €1B Bond to AI Emitters — Stays Intact 05.06.2026 - Bild: über boerse-global.de

European chip stocks took a hit today after Broadcom’s quarterly update disappointed a market hungry for bigger AI promises. Ams Osram bore the brunt of the selloff, shedding 5.2 percent to trade at €21.90 — more than Infineon’s 3.4 percent retreat or STMicroelectronics’ 2.6 percent slide. The trigger was not an outright miss: Broadcom posted $22.2 billion in second-quarter revenue, up 50 percent year on year, but its 2027 AI chip revenue target was merely reaffirmed rather than raised. For a sector that had priced in acceleration, that was enough to spark profit-taking.

Yet the Vienna-based sensor and optoelectronics group is navigating a far more consequential transformation than today’s share-price wobble suggests. Wednesday’s selloff tore less than a week’s gain from a stock that has still climbed roughly 158 percent since the start of the year — a rally built on operational turnarounds, hefty divestitures and a technological pivot toward artificial intelligence and augmented reality.

The most immediate marker is the upcoming annual general meeting on 10 June 2026 in Premstätten. Shareholders must have submitted their depository confirmations by today to vote. Two supervisory board seats are up for grabs as Andreas Gerstenmayer and Arunjai Mittal step down — a non-trivial change at a company deep in restructuring. The ballot will also cover the 2025 annual and consolidated accounts, the discharge of management, the appointment of auditors for 2026, and the cancellation of a contingent capital from 2017.

Operationally, Ams Osram’s first-quarter numbers already showed the restructuring is gaining traction. Revenue reached €796 million, the adjusted EBITDA margin stood at 16.5 percent, and free cash flow turned positive at €37 million. Management is guiding for free cash flow above €300 million for the full year 2026 — a target that looks more credible given the improving financing backdrop.

Should investors sell immediately? Or is it worth buying Ams Osram?

The company has placed €1 billion in senior notes carrying a 7.25 percent coupon and maturing in 2032. That refinancing is part of a broader effort to cut annual financing costs from as much as €300 million currently to under €150 million by 2028. Meanwhile, the sale of the non-optical sensors division to Infineon should close in the second quarter, pending antitrust clearance. Combined with other divestments, Ams Osram expects total proceeds of roughly €670 million.

Adding to the portfolio clean-up, a smaller but strategic deal emerged this week: Ams Osram is selling its CMOS image sensor business to Indie Semiconductor for around $40 million. The proceeds will further shore up the balance sheet and sharpen the focus on sensing and optoelectronics.

On the technology side, the company is pressing ahead with two high-growth vectors. In digital photonics, it demonstrated a prototype of optical interconnects based on micro-emitter arrays in the first quarter and has already signed a development agreement with an industry partner. The technology targets hyper-scaler AI data centres — a market where Ams Osram hopes to embed its components. In augmented reality, it is already supplying parts for current smart glasses, and CEO Aldo Kamper aims to complete the product portfolio to become a key enabler for the next generation of AI-powered AR eyewear. The company estimates component content per device at €50 to €100, though no major orders have been announced yet.

Ams Osram at a turning point? This analysis reveals what investors need to know now.

A quiet but significant signal came from the medical-sensor vertical. Hardware developer MIKROE recently introduced a board based on Ams Osram’s AS7058A analog front-end, capable of simultaneously measuring heart rate, ECG and bioimpedance. Such collaborations underscore how deeply the company is embedded in specialised health sensing — a niche that provides recurring revenue and buffers against swings in consumer electronics.

The stock now trades at roughly €21.90, more than 90 percent above its 200-day moving average of €11.32 and about 18 percent below its 52-week high of €26.70. The next tangible catalyst is the closing of the Infineon deal by mid-year, which should clear the path to sustained positive free cash flow from 2027. In the short term, the market’s attention will remain on AI demand signals and the pace of sector earnings. But for Ams Osram, the story is increasingly about what it is becoming — not what Broadcom’s forecast did today.

Ad

Ams Osram Stock: New Analysis - 5 June

Fresh Ams Osram information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Ams Osram analysis...

en | AT0000A3EPA4 | DESPITE | boerse | 69485283 |